Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1263279-79-3

Post Buying Request

1263279-79-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1263279-79-3 Usage

General Description

6-Methoxy-pyrazolo[1,5-b]pyridazine-3-carboxylic acid methyl ester is a chemical compound that belongs to the class of pyrazolopyridazine derivatives. It is used in various fields such as pharmaceuticals, agrochemicals, and materials science due to its diverse biological activities and potential therapeutic applications. 6-Methoxy-pyrazolo[1,5-b]pyridazine-3-carboxylic acid methyl ester has shown potential anti-inflammatory, anti-cancer, and antimicrobial properties in various studies. Its methyl ester form indicates that it is a methylated derivative of the parent compound, which may offer different properties and applications. Overall, 6-Methoxy-pyrazolo[1,5-b]pyridazine-3-carboxylic acid methyl ester is a versatile chemical with potential for various applications in the fields of medicine and materials science.

Check Digit Verification of cas no

The CAS Registry Mumber 1263279-79-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,3,2,7 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1263279-79:
(9*1)+(8*2)+(7*6)+(6*3)+(5*2)+(4*7)+(3*9)+(2*7)+(1*9)=173
173 % 10 = 3
So 1263279-79-3 is a valid CAS Registry Number.

1263279-79-3Downstream Products

1263279-79-3Relevant articles and documents

HETEROCYCLYL SUBSTITUTED PYRROLOPYRIDINES THAT ARE INHIBITORS OF THE CDK12 KINASE

-

Page/Page column 93; 94, (2019/04/16)

This invention relates to compounds that are inhibitors of the CDK12 kinase. The compounds are useful in the treatment of disorders mediated by CDK12 kinase including myotonic dystrophy type 1 (DM1) and other disorders caused by the generation of RNA repeat expansion transcripts. In particular,the invention relates to compounds of the formula (I), or a pharmaceutically acceptable salts or N-oxides thereof, wherein R1a, R2, R3, R4a, R4b and R4c are as defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1263279-79-3